Oncology and Hematology - Prova Education

Episodes 1-16 of 42

- Arjun V. Balar, MD
  Peer
- Daniel P. Petrylak, MD
  Peer
0
CME/CE
0.50 credits
Advances in the Management of mUC: The State of the Union
0.50 credits
- Javier Cortes, MD, PhD
  Peer
- Sara A. Hurvitz, MD, FACP
  Peer
2
CME/CE
0.25 credits
State of the Union: Advances in the Management HER2+ mBC
0.25 credits
- Paul Paik, MD
  Peer
- Joshua K. Sabari, MD
  Peer
5
CME/CE
Meeting Future Global Challenges: Case-Based Presentations in the Management of NSCLC
Meeting Future Global Challenges: Case-Based Presentations in the Management of NSCLC
0.25 credits
Meeting Future Global Challenges: Case-Based Presentations in the Management ...
0.25 credits
- Loretta J. Nastoupil, MD
  Peer
- John P. Leonard, MD
  Peer
4
CME/CE
Applying Data to Patient Care: Case Review in Follicular Lymphoma
Applying Data to Patient Care: Case Review in Follicular Lymphoma
0.25 credits
Applying Data to Patient Care: Case Review in Follicular Lymphoma
0.25 credits
- Loretta J. Nastoupil, MD
  Peer
- Gilles Salles, MD
  Peer
5
CME/CE
Critical Review of Data in Follicular Lymphoma
Critical Review of Data in Follicular Lymphoma
0.25 credits
Critical Review of Data in Follicular Lymphoma
0.25 credits
- Paul Paik, MD
  Peer
- Viola Zhu, MD
  Peer
1
CME/CE
Therapy Gaps: Identifying New Targets in the Management of NSCLC
Therapy Gaps: Identifying New Targets in the Management of NSCLC
0.25 credits
Therapy Gaps: Identifying New Targets in the Management of NSCLC
0.25 credits
- Loretta J. Nastoupil, MD
  Peer
- Matthew J. Matasar, MD
  Peer
5
CME/CE
Creating Personalized Care in Relapsed/Refractory Follicular Lymphoma
Creating Personalized Care in Relapsed/Refractory Follicular Lymphoma
0.25 credits
Creating Personalized Care in Relapsed/Refractory Follicular Lymphoma
0.25 credits
- Julien Taieb, MD, PhD
  Peer
- Scott Kopetz, MD, PhD
  Peer
5
CME/CE
Optimizing Treatment and Patient Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
Optimizing Treatment and Patient Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
Optimizing Treatment and Patient Selection in BRAF V600E-Mutated Metastatic C...
0.25 credits
- Daniel Catenacci, MD
  Peer
- Yelena Janjigian, MD
  Peer
5
CME/CE
Applying Clinical Evidence in Advanced HER2-Positive Gastric Cancer
Applying Clinical Evidence in Advanced HER2-Positive Gastric Cancer
0.25 credits
Applying Clinical Evidence in Advanced HER2-Positive Gastric Cancer
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Ana Oaknin, MD
  Peer
3
CME/CE
Keeping Pace in Women’s Cancer: Clinical Considerations for Endometrial Cancer—Global Perspectives
Keeping Pace in Women’s Cancer: Clinical Considerations for Endometrial Cancer—Global Perspectives
0.25 credits
Keeping Pace in Women’s Cancer: Clinical Considerations for Endometrial Cance...
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Nicoletta Colombo, MD
  Peer
- Christine Ghione
  Peer
5
CME/CE
Keeping Pace in Women’s Cancer: Targeting Advanced Endometrial Cancer
Keeping Pace in Women’s Cancer: Targeting Advanced Endometrial Cancer
0.25 credits
Keeping Pace in Women’s Cancer: Targeting Advanced Endometrial Cancer
0.25 credits
- Paul Paik, MD
  Peer
- Jyoti D. Patel, MD, FASCO
  Peer
6
CME/CE
Liquid and Tissue Biopsy in the Treatment of NSCLC: Focus on MET Gene Aberrations
Liquid and Tissue Biopsy in the Treatment of NSCLC: Focus on MET Gene Aberrations
0.25 credits
Liquid and Tissue Biopsy in the Treatment of NSCLC: Focus on MET Gene Aberrat...
0.25 credits
- Shannon L. Meeks, MD
  Peer
- Jonathan C. Roberts, MD
  Peer
4
CME/CE
Practical Guidance for Surveillance and Reporting in Hemophilia A
Practical Guidance for Surveillance and Reporting in Hemophilia A
0.25 credits
Practical Guidance for Surveillance and Reporting in Hemophilia A
0.25 credits
- Shannon L. Meeks, MD
  Peer
- Cindy Leissinger, MD
  Peer
5
CME/CE
What You Need to Know About Pharmacovigilance in Novel Hemophilia A Treatment
What You Need to Know About Pharmacovigilance in Novel Hemophilia A Treatment
0.25 credits
What You Need to Know About Pharmacovigilance in Novel Hemophilia A Treatment
0.25 credits
- Peter Schmid, FRCP, MD, PhD
  Peer
- Javier Cortes, MD, PhD
  Peer
6
CME/CE
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
0.25 credits
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
0.25 credits
- Charles E. Geyer, Jr., MD, FACP
  Peer
- Hope S. Rugo, MD
  Peer
6
CME/CE
Evolving Strategies in the Management of HER2-Positive Early-Stage Breast Cancer
Evolving Strategies in the Management of HER2-Positive Early-Stage Breast Cancer
0.25 credits
Evolving Strategies in the Management of HER2-Positive Early-Stage Breast Cancer
0.25 credits

Prev
1
2
3
Next

1/3